Solvotrin Therapeutics Solvotrin Therapeutics is a drug development company focused on chemical modifications of known drugs. | Vertex Pharmaceuticals Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines. | Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. | ||
Founding Date | Founding Date 2009 | Founding Date 1989 | Founding Date 1985 | Founding Date 1904 |
Type | Type Private | Type Public | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations IE HQ | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more | |
Employees | Employees 225% increase | Employees 5,40013% increase | Employees 8,933 | Employees 7,5692% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 126.3 b | Valuation ($) 4.1 b | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $9.9b (FY, 2023) | Revenue (est.) ¥12.2b (FY, 2023) | Revenue (est.) $7.9b (FY, 2020) |
Cost of goods | Cost of goods N/A | Cost of goods $1.3b (FY, 2023) | Cost of goods ¥4.5b (FY, 2023) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $8.6b (FY, 2023) | Gross profit ¥7.8b (FY, 2023) | Gross profit $4.5b (FY, 2020) |
Net income | Net income N/A | Net income $3.6b (FY, 2023) | Net income ¥1.9b (FY, 2023) | Net income N/A |
Operating ⚠ | ||||
Trademark Applications | Trademark Applications N/A | Trademark Applications N/A | Trademark Applications 3 (Sep, 2023) | Trademark Applications 1 (Dec, 2020) |
Trademarks | Trademarks N/A | Trademarks N/A | Trademarks 45 (Sep, 2023) | Trademarks 4 (Dec, 2020) |
Funding | ||||
Total funding raised | Total funding raised $ 4.4m | Total funding raised $ 2.4m | Total funding raised N/A | Total funding raised N/A |